|
SBF2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.818600E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.283800E-03 |
| Normal-vs-Stage2 |
7.742000E-03 |
| Normal-vs-Stage3 |
3.366000E-01 |
| Normal-vs-Stage4 |
1.632820E-01 |
| Stage1-vs-Stage2 |
2.219000E-01 |
| Stage1-vs-Stage3 |
1.085810E-01 |
| Stage1-vs-Stage4 |
4.615000E-01 |
| Stage2-vs-Stage3 |
5.111700E-02 |
| Stage2-vs-Stage4 |
1.460550E-01 |
| Stage3-vs-Stage4 |
6.508400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.602500E-02 |
| Normal-vs-AfricanAmerican |
6.779700E-02 |
| Normal-vs-Asian |
1.101760E-02 |
| Caucasian-vs-AfricanAmerican |
3.409000E-01 |
| Caucasian-vs-Asian |
2.446400E-01 |
| AfricanAmerican-vs-Asian |
9.323200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.344370E-01 |
| Normal-vs-Female |
2.204200E-03 |
| Male-vs-Female |
1.637970E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.804500E-03 |
| Normal-vs-Age(41-60Yrs) |
3.636000E-02 |
| Normal-vs-Age(61-80Yrs) |
5.310400E-02 |
| Normal-vs-Age(81-100Yrs) |
8.452300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.077000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.259000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.848400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.335200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.365900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.635700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.726570E-01 |
| Classical-VS-Follicular |
1.102170E-01 |
| Classical-VS-Other |
6.091400E-01 |
| Classical-VS-Normal |
6.484900E-03 |
| Tall-VS-Follicular |
1.722430E-02 |
| Tall-VS-Other |
8.437800E-01 |
| Tall-VS-Normal |
7.187600E-01 |
| Follicular-VS-Other |
3.624400E-01 |
| Follicular-VS-Normal |
1.100550E-03 |
| Other-VS-Normal |
6.468000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.040210E-02 |
| Normal-vs-N1 |
3.621800E-01 |
| N0-vs-N1 |
2.545800E-01 |
|
|
